Combining Chinese and Western Medicine for Ankylosing Spondylitis
Part of Bones, joints & muscles clinical trials.
This study tests whether combining traditional Chinese medicine with standard Western treatments can help ankylosing spondylitis (a condition causing spine stiffness and inflammation) work better and improve your quality of life. Researchers will follow patients over time to see how well this combined approach works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ankylosing spondylitis or axial spondyloarthritis using standard medical criteria
- You are between 18 and 75 years old
- You do not have other autoimmune diseases like rheumatoid arthritis or Sjögren's syndrome
- You are not pregnant or breastfeeding
- You do not have serious heart, brain, liver, kidney disease, or cancer
- You can understand and communicate in the study's language and provide your own information
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if combining traditional Chinese medicine with standard Western medicine can better treat ankylosing spondylitis. The goal is to see if this approach can reduce inflammation and improve your symptoms, such as back pain and stiffness.
This study tracks how axial spondyloarthritis progresses over time in Chinese patients. It helps doctors understand the natural course of the disease and improve care.
This trial studies whether secukinumab (a targeted medicine given by injection) can reduce symptoms and disease activity in adults with active ankylosing spondylitis. You may be considered if other common anti-inflammatory medicines have not worked well enough or you could not take them.
This trial tests whether adding a common antibiotic (benzathine penicillin) to a standard biologic drug (etanercept) can better treat spondyloarthritis. It may help if you have active disease and are free of certain infections.
This study follows patients with spondyloarthritis over time to better understand the condition. It collects information from hospital visits and may help improve care for people with this type of arthritis.
This study tests a new medication (called 608) for adults with active ankylosing spondylitis (AS). It aims to see if the drug can reduce AS symptoms and improve quality of life.
Hear when a new Ankylosing Spondylitis (AS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.